Cigna Group’s (CI) Outperform Rating Reiterated at Royal Bank Of Canada

Royal Bank Of Canada reiterated their outperform rating on shares of Cigna Group (NYSE:CI) in a report issued on Thursday morning,Benzinga reports. The firm currently has a $337.00 target price on the health services provider’s stock.

Several other analysts have also recently commented on the company. Piper Sandler decreased their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 26th. Sanford C. Bernstein boosted their price objective on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Finally, Guggenheim upped their target price on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $338.24.

Cigna Group Stock Up 1.1%

Shares of NYSE CI opened at $270.92 on Thursday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The business has a fifty day moving average of $278.79 and a two-hundred day moving average of $280.50. The stock has a market cap of $71.59 billion, a PE ratio of 11.21, a PEG ratio of 0.91 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts expect that Cigna Group will post 30.5 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Activity

In related news, insider Nicole Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cigna Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. GQG Partners LLC acquired a new stake in shares of Cigna Group in the second quarter valued at approximately $1,628,918,000. Bank of America Corp DE acquired a new position in Cigna Group during the second quarter worth $827,692,000. Legal & General Group Plc bought a new position in Cigna Group in the second quarter valued at $542,779,000. Boston Partners increased its stake in Cigna Group by 314.6% in the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after buying an additional 1,243,056 shares during the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new stake in Cigna Group in the 2nd quarter valued at $241,312,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.